Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Neuroprotection by central nervous system remyelination: Molecular, cellular, and functional considerations.
Regulation of Oligodendrocyte Differentiation and Myelination by Nuclear Receptors: Role in Neurodegenerative Disorders.
Oligodendrocyte differentiation.
The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.
Effects of chlorogenic acid on adenine nucleotides hydrolyzing enzyme activities and expression in platelets of rats experimentally demyelinated with ethidium bromide.
Geographic population structure in Epstein-Barr Virus revealed by comparative genomics.
In-depth cerebrospinal fluid quantitative proteome and deglycoproteome analysis; presenting a comprehensive picture of pathways and processes affected by multiple sclerosis.
Myelin Avoids the JAM.
Genetics of rat neuroinflammation.
Gait characteristics according to pyramidal, sensory and cerebellar EDSS subcategories in people with multiple sclerosis.
The Role of Imaging for Trigeminal Neuralgia: A Segmental Approach to High-Resolution MRI.
Temporal Course of Neurodegenerative Effects on Cognition in Old Age .
MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis.
Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis.
Late-onset myasthenia gravis. Follow-up of 113 patients diagnosed after age 60.
B cells of multiple sclerosis patients induce autoreactive proinflammatory T cell responses.
Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod.
Early Relapsing Multiple Sclerosis.
[Pontine reversible leucopathy in an AIDS patient associated with highly active antiretroviral therapy (HAART): Report of one case].
Distinct T cell signatures define subsets of patients with multiple sclerosis.
Gait variability across the disability spectrum in people with multiple sclerosis.
Optic neuritis with TNF alpha antagonists.
Neuroimmune mechanisms in Krabbe's disease.
Erythroblastaemia in natalizumab-treated patients with multiple sclerosis.
Health Literacy and Outcomes in Multiple Sclerosis.

Pages